Apoptosis inhibition or inflammation: The role of NAIP protein expression in Hodgkin and non-Hodgkin lymphomas compared to non-neoplastic lymph node

Journal of Inflammation

Volumn 9, Issue , 2012, Pages

  Mazrouei, Safoura ^a,c   Ziaei, Amin ^a   Tanhaee, Amir ^a   Keyhanian, Kianoosh ^d   Esmaeili, Mahdad ^a   Baradaran, Azar ^a   Salehi, Mansoor ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Medical Genetics Center of Genome   (Iran)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Hodgkin lymphoma; Inflammasome; Inflammatory caspases; Inhibitor of apoptosis protein; NAIP BIRC1; Non Hodgkin lymphoma; Semi quantitative immuno flourecent staining

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NEURONAL APOPTOSIS INHIBITORY PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATION; LYMPHOID HYPERPLASIA; MALE; NONHODGKIN LYMPHOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING;

INTRACISTERNAL A-PARTICLES;

EID: 84857259241     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-4     Document Type: Article

References (34)

1. Nachmias B, Ashhab Y, Ben-Yehuda D: The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004, 14:231-243. (Pubitemid 38824584)
2. Herman MD, Moche M, Flodin S, Welin M, Tresaugues L, Johansson I, Nilsson M, Nordlund P, Nyman T: Structures of BIR domains from human NAIP and cIAP2. Acta Crystallogr Sect F Struct Biol Cryst Commun 2009, 65:1091-1096.
3. Karimpour S, Davoodi J, Ghahremani MH: Integrity of ATP binding site is essential for effective inhibition of the intrinsic apoptosis pathway by NAIP. Biochem Biophys Res Commun 2011, 407:158-162.
4. Davoodi J, Ghahremani MH, Es-Haghi A, Mohammad-Gholi A, Mackenzie A: Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9. Int J Biochem Cell Biol 2010, 42:958-964.
5. Liston P, Fong WG, Korneluk RG: The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003, 22:8568-8580. (Pubitemid 38019194)
6. Jantas D, Lorenc-Koci E, Kubera M, Lason W: Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons. Neurotoxicology 2011, 32(6):845-856, Epub 2011 Jun 1.
7. de Graaf AO, van Krieken JH, Tonnissen E, Wissink W, van de Locht L, Overes I, Dolstra H, de Witte T, van der Reijden BA, Jansen JH: Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies. Br J Haematol 2005, 130:852-859. (Pubitemid 43899726)
8. Grzybowska-Izydorczyk O, Cebula B, Robak T, Smolewski P: Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia. Eur J Cancer 2010, 46:800-810.
9. Choi J, Hwang YK, Sung KW, Lee SH, Yoo KH, Jung HL, Koo HH, Kim HJ, Kang HJ, Shin HY, Ahn HS: Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 2007, 109:471-477. (Pubitemid 46105940)
10. Choi J, Hwang YK, Choi YJ, Yoo KE, Kim JH, Nam SJ, Yang JH, Lee SJ, Yoo KH, Sung KW, et al: Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer. J Korean Med Sci 2007, 22(Suppl):S17-S23.
11. Schlette EJ, Medeiros LJ, Goy A, Lai R, Rassidakis GZ: Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol 2004, 22:1682-1688. (Pubitemid 41079807)
12. Grzybowska-Izydorczyk O, Smolewski P: The role of the inhibitor of apoptosis protein (IAP) family in hematological malignancies. Postepy Hig Med Dosw (Online) 2008, 62:55-63.
13. Wang L, Zhang Q, Liu B, Han M, Shan B: Challenge and promise: roles for Livin in progression and therapy of cancer. Mol Cancer Ther 2008, 7:3661-3669.
14. Kasof GM, Gomes BC: Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001, 276:3238-3246.
15. Verhagen AM, Coulson EJ, Vaux DL: Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2001, 2(7):REVIEWS3009, Epub 2001 Jul 5.
16. Schimmer AD: Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004, 64:7183-7190.
17. Dubrez-Daloz L, Dupoux A, Cartier J: IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 2008, 7:1036-1046.
18. Yan B: Research progress on Livin protein: an inhibitor of apoptosis. Mol Cell Biochem 2011, 357(1-2):39-45, Epub 2011 May 27.
19. Maier JK, Lahoua Z, Gendron NH, Fetni R, Johnston A, Davoodi J, Rasper D, Roy S, Slack RS, Nicholson DW, MacKenzie AE: The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 2002, 22:2035-2043. (Pubitemid 35386504)
20. Chamaillard M, Girardin SE, Viala J, Philpott DJ: Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 2003, 5:581-592. (Pubitemid 37080669)
21. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009, 10:241-247.
22. Maier JK, Balabanian S, Coffill CR, Stewart A, Pelletier L, Franks DJ, Gendron NH, MacKenzie AE: Distribution of neuronal apoptosis inhibitory protein in human tissues. J Histochem Cytochem 2007, 55:911-923. (Pubitemid 47293837)
23. Martinon F, Tschopp J: Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007, 14:10-22. (Pubitemid 44911890)
24. Martinon F, Gaide O, Petrilli V, Mayor A, Tschopp J: NALP inflammasomes: a central role in innate immunity. Semin Immunopathol 2007, 29:213-229. (Pubitemid 47416217)
25. Ting JP, Davis BK: CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 2005, 23:387-414. (Pubitemid 40563175)
26. Krajewska M, Krajewski S, Banares S, Huang X, Turner B, Bubendorf L, Kallioniemi OP, Shabaik A, Vitiello A, Peehl D, et al: Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003, 9:4914-4925. (Pubitemid 37323298)
27. Mani H, Jaffe ES: Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma 2009, 9:206-216.
28. Diehl V: Hodgkin's disease-from pathology specimen to cure. N Engl J Med 2007, 357:1968-1971.
29. Kuppers R: Molecular biology of Hodgkin lymphoma. Hematol Am Soc Hematol Educ Program 2009, 2009:491-496.
30. Berglund M, Enblad G, Thunberg U, Amini RM, Sundstrom C, Roos G, Erlanson M, Rosenquist R, Larsson C, Lagercrantz S: Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma. Mod Pathol 2007, 20:63-75. (Pubitemid 44967951)
31. Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Glenn MJ, et al: Non-Hodgkin's Lymphomas. J Natl Compr Canc Netw 2011, 9:484-560.
32. Salaverria I, Siebert R: Follicular lymphoma grade 3B. Best Pract Res Clin Haematol 2011, 24:111-119.
33. Salehi M, Barron M, Merry BJ, Goyns MH: Fluorescence in situ hybridization analysis of the fos/jun ratio in the ageing brain. Mech Ageing Dev 1999, 107:61-71. (Pubitemid 29113074)
34. Kabiri Z, Salehi M, Mokarian F, Mohajeri MR, Mahmoodi F, Keyhanian K, Doostan I, Ataollahi MR, Modarressi MH: Evaluation of ARG protein expression in mature B cell lymphomas compared to non-neoplastic reactive lymph node. Cell Immunol 2009, 259:111-116.